Generate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcomes.

NCT05069259 · clinicaltrials.gov ↗
TERMINATED
Status
18
Enrollment
INDUSTRY
Sponsor class

Stopped Study was terminated due to difficulty in enrolling targeted number of participants. There were no safety and/or efficacy concerns in the decision to stop enrollment.

Conditions

Interventions

Sponsor

Pfizer